ArticleJournal of applied clinical medical physics2026
Multicenter development and external validation of clinical-radiomics models to predict surgically confirmed upstaging in biopsy-proven DCIS using DCE-MRI.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
purposeDuctal carcinoma in situ (DCIS) diagnosed on core biopsy is frequently upgraded to invasive carcinoma at surgery, which may change indications for sentinel lymph node biopsy. Routine breast MRI has limited ability to detect occult invasion preoperatively. This study aimed to develop and externally validate an MRI-based model combining clinical variables, conventional MRI findings, and dynamic contrast-enhanced (DCE) MRI radiomics to predict invasive upgrade in biopsy-proven DCIS.
methodsThis retrospective multicenter study enrolled 478 patients from three hospitals (2014-2019). Center 1 contributed 314 patients, randomly split into a training set (n = 251) and an internal test set (n = 63); Centers 2 (n = 39) and 3 (n = 62) formed two independent external test sets. Radiologists assessed conventional MRI features, including lesion size, enhancement descriptors, and diffusion-derived apparent diffusion coefficient metrics. Tumors were segmented on DCE MRI. Radiomics features with intraclass correlation coefficient > 0.85 were z-score normalized, selected using least absolute shrinkage and selection operator regression, and used to train multiple machine learning classifiers; the best-performing model generated a radiomics score. Model selection and hyperparameter tuning were performed by cross-validation within the training set only. Clinico-radiologic, radiomics, and combined models were evaluated using receiver operating characteristic (ROC) curve analysis, calibration, and decision curve analysis, the area under the curve (AUC) was calculated.
resultsSix clinico-radiologic factors and 13 radiomic features were retained. In the two external test sets, the clinico-radiologic, radiomics, and combined models achieved AUCs of 0.61 (95% CI, 0.43-0.79) and 0.71 (0.58-0.83), 0.70 (0.54-0.86) and 0.71 (0.58-0.84), and 0.76 (0.60-0.91) and 0.77 (0.65-0.89), respectively. The combined model provided the highest net benefit on decision curve analysis.
conclusionA combined clinico-radiologic and DCE-MRI radiomics model showed multicenter, externally validated performance for preoperative prediction of invasive upgrade in DCIS, supporting risk stratification for surgical planning.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.